Study May Lead to Relief for Anxiety Disorder - Beyond Vital Signs
Study May Lead to Relief for Anxiety Disorder
As part of a multi-center research study, SLU researchers are exploring the use of an investigational drug for the treatment of generalized anxiety disorder.
Generalized anxiety disorder is the most common cause of anxiety symptoms in adults and can affect 3.1 percent of the population in any given year, said George Grossberg, M.D., professor of psychiatry and principal investigator.
“People who have generalized anxiety disorder show excessive amounts of anxiety, worry and preoccupation on a number of different things, on a day-to-day basis for at least six months,” Grossberg said.
According to Grossberg, the extreme amount of anxiety is difficult to control, which can cause difficulty sleeping, lack of energy, difficulty concentrating or focusing, and irritable and tense feelings.
Treatment approaches for generalized anxiety disorder typically involve medication, cognitive therapy or a combination of the two.
Investigators will enroll 660 men and women who are 18 to 70 years old who have been diagnosed with generalized anxiety disorder in the randomized, double-blind, placebo-controlled study. Of the 40 study centers across the United States, SLU is the only study center in the St. Louis area.